ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1872 • 2013 ACR/ARHP Annual Meeting

    Gene-Body Mass Index Interactions Are Associated With Methotrexate Toxicity in Rheumatoid Arthritis

    Stella Aslibekyan1, Jin Sha1, David T. Redden2, Larry W. Moreland3, James R. O'Dell4, Jeffrey R. Curtis5, Ted R. Mikuls6, S. Louis Bridges Jr.7 and Donna K. Arnett1, 1University of Alabama at Birmingham, Birmingham, AL, 2Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 3Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 5Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Response to methotrexate (MTX) therapy in rheumatoid arthritis (RA) is highly heterogeneous, with both genetic and environmental factors contributing to the efficacy and toxicity…
  • Abstract Number: 1873 • 2013 ACR/ARHP Annual Meeting

    Use Of Mendelian Randomization Associates Increased Serum Urate Caused By Genetic Variation In Uric Acid Transporters With Improved Renal Function

    Tony R. Merriman1, Tanya Flynn2, Janak de Zoysa3, Nicola Dalbeth4 and Kim Hughes2, 1Department of Biochemistry, University of Otago, Dunedin, New Zealand, 2University of Otago, Dunedin, New Zealand, 3Waitemata District Health Board, Auckland, New Zealand, 4Medicine, University of Auckland, Auckland, New Zealand

    Background/Purpose: Hyperuricemia is the central risk factor for gout. In observational studies hyperuricemia also predicts the development and progression of chronic kidney disease independent of…
  • Abstract Number: 1874 • 2013 ACR/ARHP Annual Meeting

    Genome-Wide Profiling Identifies Significant Differences Between The T-Lymphocyte and B-Lymphocyte Methylomes In Healthy Individuals

    John Glossop1,2, Nicola Nixon2, Richard Emes3, Kim Haworth1, Jonathon Packham2, Peter Dawes2, Anthony Fryer1, Derek Mattey1,2 and William Farrell1, 1Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, United Kingdom, 2Rheumatology, Haywood Rheumatology Centre, Stoke-on-Trent, United Kingdom, 3School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonnington, United Kingdom

    Background/Purpose: Multiple reports now describe changes to the DNA methylome in a variety of autoimmune disorders, such as rheumatoid arthritis. In many cases, these studies…
  • Abstract Number: 1875 • 2013 ACR/ARHP Annual Meeting

    A Dense Mapping Of Human Leukocyte Antigen Region For Study Of Interaction With Smoking In The Development Of Rheumatoid Arthritis

    Xia Jiang1, Henrik Källberg1, Lisbeth Ärlestig2, Solbritt M. Rantapää-Dahlqvist3, Lars Klareskog4, Leonid Padyukov5 and Lars Alfredsson6, 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 3Department for Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 6Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is believed to have a multifactorial etiology, involving both genetic and environmental components, and can be divided into two major subsets…
  • Abstract Number: 1876 • 2013 ACR/ARHP Annual Meeting

    Potential Chondrogenic Biomarkers For Cell-Based Therapy Monitoring In Osteoarthritis

    Beatriz Rocha1, Valentina Calamia2, Vanessa Casas3, Lucia Lourido2, Carolina Fernandez-Costa2, Patricia Fernandez-Puente2, Jesus Mateos2, Montserrat Carrascal3, Francisco J. Blanco2 and Cristina Ruiz-Romero1,4, 1Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A Coruña, Spain, 2Osteoarticular and Aging Research Laboratory, Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña, Spain, 3Laboratorio de Proteómica CSIC/UAB, Barcelona, Spain, 4CIBER-BBN, INIBIC-CHUAC, A Coruña, Spain

    Background/Purpose: Chondrogenesis occurs as a result of mesenchymal stem cells (MSCs) condensation and chondroprogenitor cell differentiation. Following chondrogenesis, the chondrocytes remain as resting cells to…
  • Abstract Number: 1877 • 2013 ACR/ARHP Annual Meeting

    A Neutrophil Signature Comprised Of Low Density Granulocyte (LDG)-Enriched Genes Is Associated With Organ-Specific Disease Activity In Systemic Lupus Erythematosus

    Michelle Petri1, Hong Fang1, Jadwiga Bienkowska2, Andrea Dearth3, Norm Allaire4 and Ann Ranger3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Translational Medicine, Biogen Idec Inc., Cambridge, MA, 3Biogen Idec Inc, Cambridge, MA, 4Biogen Idec Inc., Cambridge, MA

    Background/Purpose: The neutrophil gene signature (NGS) has recently gained interest due to new understanding of the role of neutrophils and NETosis in SLE pathogenesis. We…
  • Abstract Number: 1878 • 2013 ACR/ARHP Annual Meeting

    Proteomics Analysis Of Cartilage Secretome: A Powerful Tool For The Discovery Of OA Biomarkers

    Lucía Lourido1, Valentina Calamia1, Patricia Fernández-Puente1, Jesus Mateos1, Beatriz Rocha2, Carolina Fernández-Costa2, Francisco J. Blanco1 and Cristina Ruiz-Romero3, 1Osteoarticular and Aging Research Laboratory, Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña, Spain, 2Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A Coruña, Spain, 3Grupo de Proteomica-PBR2-ProteoRed/ISCIII Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006 A Coruña, Spain, A Coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is characterized by the progressive loss of cartilage structural extracellular matrix (ECM) components, mainly collagenous and non-collagenous proteins. The release of these…
  • Abstract Number: 1879 • 2013 ACR/ARHP Annual Meeting

    Major Histocompatibility Complex Class I Molecules Contribute To Behçet’s Disease Risk Through Both Innate and Adaptive Immune Interactions

    Michael J. Ombrello1,2, Yohei Kirino2,3, Paul de Bakker4, Ahmet Gül5, Elaine F. Remmers6 and Daniel L. Kastner7, 1Translational Genetics and Genomics Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 3Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 4Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands, 5Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 6Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 7Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD

    Background/Purpose: Behçet's Disease (BD) is a complex genetic disease of unknown etiology that is characterized by inflammatory lesions of the eyes, skin, and oro-genital mucosa.…
  • Abstract Number: 1880 • 2013 ACR/ARHP Annual Meeting

    Global Gene Expression Profiles Reveal Genetic Signatures Of Kawasaki Disease and Disease Outcome

    Long Truong Hoang1, Chiea Chuen Khor2, Ahmad Nazri Mohamed Naim3, Ling Ling3, Chisato Shimizu4, Martin L. Hibberd1 and Jane C. Burns4, 1Infectious Diseases, Genome Institute of Singapore, Singapore, Singapore, 2Human Genetics, Genome Institute of Singapore, Singapore, Singapore, 3Genome Institute of Singapore, Singapore, Singapore, 4Pediatrics, UC San Diego, School of Medicine, La Jolla, CA

    Background/Purpose: Kawasaki Disease (KD) is a self-limited vasculitis of unknown etiology that predominantly affects children younger than 5 years. The inflammation associated with KD affects…
  • Abstract Number: 1881 • 2013 ACR/ARHP Annual Meeting

    HLA-DRB1 Rheumatoid Arthritis Susceptibility Amino Acids Define Haplotypes Associated With Radiological Outcome

    Sebastien Viatte1, Annie Yarwood2, Buhm Han3,4, Soumya Raychaudhuri3, Deborah P. M. Symmons5, Jane Worthington6,7 and Anne Barton8,9, 1Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 3Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 4Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, 5Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 6Arthritis Research UK Epidemiology Unit, The University of Manchester and Rheumatoid Arthritis Consortium for Immunochip (RACI), International Consortium, United Kingdom, 7Arthritis Research UK Epidemiology Unit, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 8Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 9NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is a systematic autoimmune disease caused by the interplay between environmental and genetic risk factors. The major genetic determinants of RA…
  • Abstract Number: 1882 • 2013 ACR/ARHP Annual Meeting

    Characterizing The C-Type Lectin Domain Family 4, Member C Gene (CLEC4C) Expression In Peripheral Blood From Rheumatoid Arthritis Patients

    Annie Yarwood1, Joanna Cobb2, Kate McAllister1, Joanne Barnes1, Ernst R. Dow3, Michelle A. Penny3, Robert W. Hoffman3 and Anne Barton4,5, 1Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, Manchester, United Kingdom, 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 4Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 5NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom

    Background/Purpose: A previous hypothesis-seeking study examining baseline phenotypic expression of mRNA in a Phase 2 clinical trial of tabalumab (also known as LA294 or LY2127399)…
  • Abstract Number: 1883 • 2013 ACR/ARHP Annual Meeting

    Fine Mapping and Expression Of a Locus Overlapping 3 Types Of Inflammatory Arthritis

    Kathryn J. A Steel1, Anne Hinks1, Annie Yarwood2, Stephen Eyre3, Edward Flynn3, Paul Martin1, Anne Barton3,4 and Wendy Thomson1,5, 1Arthritis Research UK Epidemiology Unit, Manchester Academic Health Sciences Centre, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 3Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 4NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 5Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: In a recent fine-mapping study using the Immunochip array, the RUNX1 region was strongly associated with rheumatoid arthritis (RA p=5x10-10), juvenile idiopathic arthritis (JIA…
  • Abstract Number: 1884 • 2013 ACR/ARHP Annual Meeting

    Autoantibody Specificities and Type I Interferon Pathway Activation In Idiopathic Inflammatory Myopathies

    Saskia Vosslamber1, Louise Ekholm2, Anna Tjarnlund3, T.D. de Jong1, Lenka Plestilova4, Martin Klein5, Peter J. Charles6, A.E. Voskuyl7, Irene Bultink8, Michiel Pegtel1, J Vencovsky9, Ingrid E. Lundberg10 and Cornelis L. Verweij11, 1Pathology, VU University Medical Center, Amsterdam, Netherlands, 2Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 3Pathology, Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 4Department of Clinical and Experimental Rheumatology, Institute of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology, Prague, Prague, Czech Republic, 6Oxford University, Kennedy Institute of Rheumatology, Oxford, United Kingdom, 7Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 8Department of Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 9Institute of Rheumatology, Prague, Czech Republic, 10Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 11Pathology and Rheumatology, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are rare autoimmune diseases characterized by proximal muscle weakness and muscle inflammation. IIM are associated with several autoantibodies, which are…
  • Abstract Number: 1885 • 2013 ACR/ARHP Annual Meeting

    A Weighted Genetic Risk Score Using All Known Susceptibility Variants To Predict Rheumatoid Arthritis Risk

    Annie Yarwood1, Buhm Han2, Soumya Raychaudhuri2, John Bowes1, Mark Lunt3, Dimitrios A. Pappas4, Joel M. Kremer5, Jeffrey D. Greenberg6, Robert M. Plenge7, Jane Worthington8, Anne Barton9 and Stephen Eyre10, 1Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, 4Department of Medicine, Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, 5Center for Rheumatology, Albany Medical College, Albany, NY, 6Departments of Medicine (Rheum Div) and Hospital for Joint Diseases, New York Hospital for Joint Diseases, New York, NY, 7Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 8Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester, United Kingdom, 9NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 10Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Recent advances in the identification of loci associated with susceptibility to complex disease have led to methods being developed that incorporate this information into…
  • Abstract Number: 1886 • 2013 ACR/ARHP Annual Meeting

    Differential Methylation Related To Response To Etanercept In Patients With Rheumatoid Arthritis

    Amy Webster1, Darren Plant2, Mark Lunt3, Stephen Eyre4, Edward Flynn4, Paul Martin5, A. G. Wilson6, A. W. Morgan7, John Isaacs8, Jane Worthington1,9 and Anne Barton2,4, 1Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, 4Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 5Arthritis Research UK Epidemiology Unit, Manchester Academic Health Sciences Centre, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 6Genomic Medicine, The University of Sheffield, Sheffield, United Kingdom, 7Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom, 8National Institute for Health Research, Newcastle Biomedical Research Centre, Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle Upon Tyne, United Kingdom, 9The University of Manchester, Manchester, United Kingdom

    Background/Purpose: The introduction of biologic drug therapies targeting specific components of the inflammatory response represents a huge advance in the treatment of rheumatoid arthritis (RA).…
  • « Previous Page
  • 1
  • …
  • 2124
  • 2125
  • 2126
  • 2127
  • 2128
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology